Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vatalanib in metastatic neuroendocrine tumors
NCT00590343Phase 2Completed
- Sponsor
- Louisiana State University Health Sciences Center
- Start
- Nov 2004
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vatalanib in neuroendocrine tumors (NETs), sponsored by Louisiana State University Health Sciences Center. Started Nov 2004; status: completed.
02
Drugs
vatalanib
03
Conditions
neuroendocrine tumors (NETs)
Beyond the preview
Go deeper on NCT00590343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00590343.